EU Business Round-Up: BioGaia Creates Investment Arm, Boiron Grows In Spain, GSK Ends Hikma Talks
Latest European consumer health business news: BioGaia sets up an investment arm to identify interesting start-ups, France's Boiron expands its Spain offering with Iprad deal, and GSK ends talks with Hikma over the sale of its Egyptian OTC business.
You may also be interested in...
With operations in the MENA region already tracking to $700m in revenues for 2020, Hikma is looking to grow the business further after beginning negotiations with GSK to buy certain of the originator’s businesses in Egypt and Tunisia.
Homeopathy specialist Boiron its diversifying its offering into the increasingly popular probiotics segment with launches underway in France, Italy and Spain, as well as Eastern Europe.
With FSA set to publish its public register detailing which CBD supplements can lawfully remain on the UK market, what can companies do if their product doesn't make the list? Barrister Jonathan Kirk QC set out the limited options left open to firms during a recent webinar.